3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Pain, Postoperative
4
Breast Neoplasms
4
Agnosia
2
Supratentorial Neoplasms
1
Neoplasms
1
Kidney Neoplasms
1
ENT Cancers
1
Cystic Adenomatoid Malformation of Lung, Congenital
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Renal Cell
1
Bronchopulmonary Sequestration
1
Bronchogenic Cyst
1
Breast Surgery
1
Breast Cancer Female
1
Abdominal Pain
1
Interventions
Oxaliplatin
27
Fluorouracil
23
Leucovorin
22
Cetuximab
22
Bevacizumab
21
Nivolumab
16
Capecitabine
16
Irinotecan
15
pembrolizumab
11
Magnetic Resonance Spectroscopy
11
Specimen Handling
10
encorafenib
8
Folfox protocol
7
trifluridine tipiracil drug combination
6
Ipilimumab
6
Exercise
6
fludarabine
5
cemiplimab
5
Trastuzumab
5
Gemcitabine
5
Cyclophosphamide
5
Cisplatin
5
Blood Specimen Collection
5
Biopsy
5
regorafenib
4
pertuzumab
4
adagrasib
4
Trifluridine
4
Pemetrexed
4
Immune Checkpoint Inhibitors
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Colonic Neoplasms
×
Ropivacaine
×
1 year
×
Clear all
NCT04311099
2025-08-07
OPMICS
Nordsjaellands Hospital
Phase 4
Completed
360 enrolled